Background
==========

Studies on actinorhizal symbioses have benefitted greatly from several genome sequences of the actinobacterial symbiont *Frankia*sp. strains. Such strains induce root nodules and fix N~2~in a broad array of plants \[[@B1]\]. The smallest frankial genome finished to date is that of *Frankia*sp. HFPCcI3 (CcI3) that infects plants of the family Casuarinaceae; it is about 5.4 Mbp in size and encodes 4499 CDS \[[@B2]\]. A striking feature of the CcI3 genome is the presence of over 200 transposase genes or gene remnants that may play, or have played, a role in genome plasticity \[[@B3]\]. In addition, relative to other *Frankia*sp. genomes that have been sequenced, CcI3 contains few gene duplicates \[[@B2]\]. Comparative genome studies suggest that evolution has favored gene deletion rather than duplication in this strain, perhaps as an outcome of its symbiotic focus on a single, geographically limited group of plants in the Casuarinaceae \[[@B2]\].

Transcriptome sequencing of bacterial genomes has yielded surprising complexity (for a review see \[[@B4]\]). Such studies have shown differential cistron transcription within operons \[[@B5]\], small regulatory RNA transcripts \[[@B6]-[@B9]\] and numerous riboswitch controlled transcripts \[[@B10],[@B11]\]. Significant transcriptional heterogeneity has also been found in single cultures that has been ascribed to subpopulations within an otherwise synchronized bacterial population \[[@B12]\]. High throughput RNA-seq methods provide a tool for transcript quantification with a much higher dynamic range than that provided by microarray studies by relying on direct comparison of transcript abundance for assessing differential expression \[[@B13]\].

*Frankia*transcriptome studies have the potential to reveal common genes and pathways active in, or essential to, symbiosis and free-living growth. A first step to resolving symbiotic-specific expression is to gain insight into transcriptional behavior and variability in axenic culture. This work helps address the issue of cultural heterogeneity that will likely be exacerbated by physiological heterogeneity in symbiosis. A previous transcriptome study has been done using whole-genome microarrays in *Alnus*and *Myrica*root nodules using cultured *Frankia alni*strain ACN14a as a reference \[[@B14]\]. In that study, relatively few surprises were encountered and the overall transcription profile was similar in both nodule types. We focus here on an approach using transcriptome deep sequencing of cultured *Frankia*strain CcI3 grown under different conditions, and the analysis of subsequent data to provide insight into the global expression that may impinge on physiology and genome stability in *Frankia*strains.

Results and Discussion
======================

Culture characteristics and experimental design
-----------------------------------------------

As a consequence of its filamentous growth habit, *Frankia*sp. strain CcI3 grows from hyphal tips with an initial doubling time of about 18 hrs that subsequently slows to more linear growth \[[@B15]\]. As tips extend, cells left behind are physiologically in stationary phase and eventually senesce. Thus, even young cultures (defined here as three days old) have a degree of physiological heterogeneity that increases as cultures age \[[@B16]\]. This heterogeneity must be taken into account in interpreting global transcriptome analyses.

Several factors in our sampling and library creation may influence a transcriptome analysis. Single *Frankia*cultures were used in preparing RNA libraries for each sample prior to sequencing. In addition, each sample was run on the Illumina GA IIx sequencer without technical replicates. While technical and biological replicates would have eliminated two potential sources of variability in the results of this experiment, several studies have suggested that both types of variability are unlikely to influence end results \[[@B13],[@B17]\], while other studies have found significant variation among replicate samples \[[@B18],[@B19]\]. Such effects may only influence low RPKM value genes \[[@B20]\] but, as with many such studies, our results must be viewed in the light of many potential variables.

RNA sample quality and features
-------------------------------

RNA preparations used for making dscDNA libraries for Illumina sequencing had 260/280 ratios greater than 2.0 and greater than 400 to 950 ng per μl. PCR amplification using primers for the *glnA*gene failed to yield an amplicon from RNA preparations indicating very low, if any, DNA contamination. In addition, an RT-PCR assay revealed no detectable DNA within total RNA samples prepared in a separate experiment, confirming that the RNA extraction technique can apply to sensitive RNA based experiments that use strain CcI3.

Transcriptome sequencing done using 5dNH4 CcI3 cells yielded about six million reads, three million of which could be mapped to the *Frankia*sp. CcI3 genome (Table [1](#T1){ref-type="table"}). Almost 51% of the mapped reads were from rRNA or tRNA (Table [1](#T1){ref-type="table"}). An updated base-calling algorithm (RTA v. 1.6) yielded substantially higher reads for samples from 3dNH4 and 3dN2 cultures. About 26 million reads were obtained for the latter samples, with about 16 million mapped reads in each (Table [1](#T1){ref-type="table"}). Non-coding RNAs represented a greater proportion of mapped reads in these two samples, comprising nearly 80% of the total.

###### 

Dataset statistics

                   5dNH4 (\#ORFs/\#Reads^ǂ^)   3dNH4 (\#ORFs/\#Reads^ǂ^)   3dN2 (\#ORFs/\#Reads^ǂ^)
  ---------------- --------------------------- --------------------------- --------------------------
  **rRNA/tRNA**    **65/1,401,120**            **65/12,799,049**           **64/13,524,803**
  **mRNA**         **4,491/1,322,139**         **4,544/2,813,063**         **4544/2,945,205**
  hypothetical     1,355/307,027               1,363/547,196               1,363/634,786
  pseudogenes      49/8,882                    49/31,566                   49/44,989
  transposases     135/24,528                  137/62,484                  137/87,928
  phage proteins   26/12564                    26/17,292                   26/25,218
  CRISPRs          9/6,553                     9/8,926                     9/12,702

^ǂ^Includes reads that mapped ambiguously. Ambiguous reads were only counted once.

Even after ribosomal RNA depletion, non-coding sequences formed the majority of reads in all samples with the greatest reduction seen in the 5dNH4 sample (Table [1](#T1){ref-type="table"}). This relative amount of rRNA could be related to the reduction of rRNA in older cultures, as observed in stationary and death phase cultures of *E. coli*\[[@B21]\]. On the other hand, given the concentration dependence of the rRNA depletion method used in preparing the mRNA-seq libraries, a decrease in the proportion of rRNA in the five-day time point could have resulted from more efficient depletion. Incomplete depletion of rRNA populations is similar to what is observed in other studies and is related to the sheer abundance of such sequences \[[@B22]\].

The number of coding RNA reads was similar among all three samples although the read length for the 3dNH4 and 3dN2 samples was 76 versus 34 for 5dNH4. All of the pseudogenes present in the CcI3 genome had transcripts in at least two of the three genomes (Table [1](#T1){ref-type="table"}). Pseudogene transcription is presently not believed be a rare event \[[@B23]\], though many pseudogenes identified in a bacterial genome may simply be misannotated ORFS.

Functional Pathways
-------------------

The 100 genes with the highest RPKM value in each condition, omitting ribosomal RNAs, are listed in Table [2](#T2){ref-type="table"}. The number of hypothetical genes in this group range from 29 in the 3dNH4 cells to 39 in the 3dN2 cells to 43 in the 5dNH4 cells. Older cultures had more transcripts associated with tRNAs, transposases, CRISPR elements, integrases and hypothetical proteins than did younger cultures. Indeed, had they been included in the list, 18 of the 46 tRNA genes in CcI3 would have been in the top 100 most abundant transcript populations in 5dNH4 cells whereas no tRNAs were found in the top 100 transcripts in 3dN2 or 3dNH4 cell populations. The picture painted by the abundance of such transcripts is one of cells starved for essential metabolites such as amino acids, as expected in aging cells. In addition, enzymes involved in solving oxidative damage (e.g. protein-methionine-S-oxide reductase) were also more abundant in the older culture. Conversely, enzymes involved in catabolism (eg. alcohol dehydrogenase) were more frequently represented in the two younger cultures.

###### 

The top 100 highly expressed coding ORFs predicted by RPKM values

  3dNH4^1^                                    Locus tag                RPKM^2^        3dN2                                 Locus tag              RPKM          5dNH4                             Locus tag                RPKM
  ------------------------------------------- ------------------------ -------------- ------------------------------------ ---------------------- ------------- --------------------------------- ------------------------ --------------
  **heat shock protein Hsp20**                **Francci3_1179**        **10755**      **heat shock protein Hsp20**         **Francci3_1179**      **3553**      hypothetical protein              Francci3_1017            4967
  **aldehyde dehydrogenase**                  **Francci3_2944**        **7165**       **aldehyde dehydrogenase**           **Francci3_2944**      **3152**      **heat shock protein Hsp20**      **Francci3_1179**        **2077**
  **chaperonin GroEL**                        **Francci3_4398**        **5923**       **hypothetical protein**             **Francci3_1545**      **2327**      **hypothetical protein**          **Francci3_3999**        **1926**
  [cold-shock DNA-binding]{.ul}               [Francci3_0260]{.ul}     [5495]{.ul}    **transposase IS66**                 **Francci3_1864**      **2261**      **transposase IS66**              **Francci3_1864**        **1801**
  [OsmC-like protein]{.ul}                    [Francci3_4465]{.ul}     [5490]{.ul}    [hypothetical protein]{.ul}          [Francci3_2178]{.ul}   [1993]{.ul}   polysaccharide deacetylase        Francci3_0165            1616
  [co-chaperonin GroES]{.ul}                  [Francci3_0632]{.ul}     [5362]{.ul}    response regulator receiver          Francci3_0120          1823          hypothetical protein              Francci3_2101            1596
  [Hemerythrin HHE cation]{.ul}               [Francci3_1066]{.ul}     [4392]{.ul}    [Hemerythrin HHE cation]{.ul}        [Francci3_1066]{.ul}   [1807]{.ul}   phage integrase                   Francci3_4274            1451
  **hypothetical protein**                    **Francci3_1545**        **4225**       [hypothetical protein]{.ul}          [Francci3_1936]{.ul}   [1789]{.ul}   Radical SAM                       Francci3_1753            1392
  [NAD/NADP transhydrogenase]{.ul}            [Francci3_2947]{.ul}     [3226]{.ul}    [OsmC-like protein]{.ul}             [Francci3_4465]{.ul}   [1777]{.ul}   hypothetical protein              Francci3_2241            1333
  **UspA**                                    **Francci3_2760**        **3221**       **hypothetical protein**             **Francci3_3999**      **1614**      hypothetical protein              Francci3_2890            1265
  [hypothetical protein]{.ul}                 [Francci3_3494]{.ul}     [3190]{.ul}    [cold-shock DNA-binding]{.ul}        [Francci3_0260]{.ul}   [1592]{.ul}   phosphoribosyl-ATPphosphatase     Francci3_4317            1245
  [hypothetical protein]{.ul}                 [Francci3_2178]{.ul}     [3071]{.ul}    [sigma 54 modulation]{.ul}           [Francci3_0764]{.ul}   [1574]{.ul}   hypothetical protein              Francci3_0159            1184
  [sigma 54 modulation protein]{.ul}          [Francci3_0764]{.ul}     [3004]{.ul}    [cold-shock DNA-binding]{.ul}        [Francci3_4469]{.ul}   [1458]{.ul}   ribonucleaseHII                   Francci3_3588            1161
  [cold-shock DNA-binding]{.ul}               [Francci3_4469]{.ul}     [2949]{.ul}    [putative DNA-binding]{.ul}          [Francci3_1949]{.ul}   [1392]{.ul}   GDP-mannose 4,6-dehydratase       Francci3_1307            1134
  [Alcohol dehydrogenase]{.ul}                [Francci3_2945]{.ul}     [2916]{.ul}    [LuxR family regulator]{.ul}         [Francci3_0765]{.ul}   [1361]{.ul}   hypothetical protein              Francci3_4023            1122
  [putative Lsr2-like protein]{.ul}           [Francci3_3498]{.ul}     [2659]{.ul}    **chaperoninGroEL**                  **Francci3_4398**      **1199**      major facilitator superfamily     Francci3_2289            1122
  [hypothetical protein]{.ul}                 [Francci3_1936]{.ul}     [2577]{.ul}    hypothetical protein                 Francci3_4123          1176          RNA-directed DNA polymerase       Francci3_2318            1088
  [hypothetical protein]{.ul}                 [Francci3_2270]{.ul}     [2529]{.ul}    [hypothetical protein]{.ul}          [Francci3_3494]{.ul}   [1175]{.ul}   methionine-S-oxide reductase      Francci3_2268            1071
  [thioredoxin-related]{.ul}                  [Francci3_0447]{.ul}     [2355]{.ul}    [hypothetical protein]{.ul}          [Francci3_2269]{.ul}   [1174]{.ul}   HypA                              Francci3_1937            1047
  **SsgA**                                    **Francci3_3418**        **2154**       [transcriptional regulator]{.ul}     [Francci3_4255]{.ul}   [1167]{.ul}   acyltransferase 3                 Francci3_2337            987
  luciferase-like                             Francci3_2761            2117           [co-chaperoninGroES]{.ul}            [Francci3_0632]{.ul}   [1150]{.ul}   hypothetical protein              Francci3_3302            982
  [molecular chaperone DnaK]{.ul}             [Francci3_4352]{.ul}     [2036]{.ul}    hypothetical protein                 Francci3_2442          1117          Serine acetyltransferase-like     Francci3_3842            970
  [globin]{.ul}                               [Francci3_2581]{.ul}     [1935]{.ul}    **SsgA**                             **Francci3_3418**      **1043**      **hypothetical protein**          **Francci3_0227**        **970**
  [LuxR family regulator]{.ul}                [Francci3_0765]{.ul}     [1934]{.ul}    [SecE subunit]{.ul}                  [Francci3_0567]{.ul}   [1037]{.ul}   hypothetical protein              Francci3_1719            965
  thioredoxin reductase                       Francci3_4536            1913           [putative Lsr2-like protein]{.ul}    [Francci3_3498]{.ul}   [1022]{.ul}   hypothetical protein              Francci3_0238            957
  Rhodanese-like                              Francci3_0449            1881           [PEP phosphomutase]{.ul}             [Francci3_1533]{.ul}   [1005]{.ul}   hypothetical protein              Francci3_2200            947
  [carbonic anhydrase]{.ul}                   [Francci3_0708]{.ul}     [1859]{.ul}    [hypothetical protein]{.ul}          [Francci3_2270]{.ul}   [973]{.ul}    hypothetical protein              Francci3_1831            945
  **superfamily MFS_1**                       **Francci3_2752**        **1811**       chaperone hypC/hupF                  Francci3_1946          954           serine/threonine kinase           Francci3_4051            938
  hypothetical protein                        Francci3_3250            1807           transposase, IS4                     Francci3_3990          953           signal transduction kinase        Francci3_0085            938
  [exodeoxyribonuclease III]{.ul}             [Francci3_1180]{.ul}     [1754]{.ul}    [thioredoxin-related]{.ul}           [Francci3_0447]{.ul}   [951]{.ul}    hypothetical protein              Francci3_4019            922
  [PEP phosphomutase]{.ul}                    [Francci3_1533]{.ul}     [1742]{.ul}    [ATP synthase F0]{.ul}               [Francci3_3713]{.ul}   [928]{.ul}    hypothetical protein              Francci3_0396            914
  [STAS (anti-σ factor antagonist)]{.ul}      [Francci3_0441]{.ul}     [1728]{.ul}    mannose 4,6-dehydratase              Francci3_1053          921           CRISPR-associated protein         Francci3_0021            899
  [hypothetical protein]{.ul}                 [Francci3_1935]{.ul}     [1687]{.ul}    phage integrase                      Francci3_4338          919           hypothetical protein              Francci3_0038            899
  sigma 38                                    Francci3_3505            1673           protein of unknown function          Francci3_3347          892           Recombinase                       Francci3_3989            898
  **hypothetical protein**                    **Francci3_0227**        **1665**       transposase, IS4                     Francci3_0391          878           aldo/keto reductase               Francci3_3416            890
  hypothetical protein                        Francci3_1615            1634           **major facilitator MFS_1**          **Francci3_2752**      **865**       transposase, IS4                  Francci3_1873            875
  [hypothetical protein]{.ul}                 [Francci3_2943]{.ul}     [1629]{.ul}    [NAD/NADP transhydrogenase]{.ul}     [Francci3_2947]{.ul}   [863]{.ul}    Excisionase/Xis, DNA-binding      Francci3_0405            875
  [hypothetical protein]{.ul}                 [Francci3_0054]{.ul}     [1629]{.ul}    hypothetical protein                 Francci3_4084          855           transposase, IS4                  Francci3_0151            874
  **transposase IS66**                        **Francci3_1864**        **1625**       *hypothetical protein*               *Francci3_2380*        *839*         CRISPR-associated protein         Francci3_0020            869
  [transcriptional regulator, CarD]{.ul}      [Francci3_4255]{.ul}     [1596]{.ul}    hypothetical protein                 Francci3_4114          821           *CRISPR-associated protein*       *Francci3_3345*          *863*
  alanine dehydrogenase/PNT-like              Francci3_2946            1532           [Alcohol dehydrogenase]{.ul}         [Francci3_2945]{.ul}   [796]{.ul}    glycosyl transferase              Francci3_3318            859
  [serine phosphatase]{.ul}                   [Francci3_3249]{.ul}     [1453]{.ul}    [hypothetical protein]{.ul}          [Francci3_3791]{.ul}   [782]{.ul}    metallophosphoesterase            Francci3_1990            839
  chaperonin GroEL                            Francci3_0633            1439           [acyl-CoA dehydrogenase]{.ul}        [Francci3_1000]{.ul}   [781]{.ul}    hypothetical protein              Francci3_3339            837
  [hypothetical protein]{.ul}                 [Francci3_0949]{.ul}     [1437]{.ul}    *transcriptional regulator*          *Francci3_3081*        *780*         *transcriptional regulator*       *Francci3_3081*          *834*
  [transcription factor WhiB]{.ul}            [Francci3_3759]{.ul}     [1430]{.ul}    *hypothetical protein*               *Francci3_0037*        *779*         hypothetical protein              Francci3_3317            826
  fatty acid desaturase, type 2               Francci3_0307            1430           Amino acid adenylation               Francci3_2461          777           hypothetical protein              Francci3_4072            824
  STAS                                        Francci3_4302            1405           hypothetical protein                 Francci3_1615          775           transcriptional regulator         Francci3_0908            816
  Heavy metal transportprotein                Francci3_0489            1368           hypothetical protein                 Francci3_2179          775           hypothetical protein              Francci3_4129            809
  sigma-24                                    Francci3_3768            1353           [hypothetical protein]{.ul}          [Francci3_1534]{.ul}   [773]{.ul}    transposase, IS4                  Francci3_4227            803
  transcriptional regulator, TetR             Francci3_2758            1349           hypothetical protein                 Francci3_2329          767           **Antibiotic biosynthesis**       **Francci3_0875**        **800**
  [hypothetical protein]{.ul}                 [Francci3_3417]{.ul}     [1343]{.ul}    [carbonic anhydrase]{.ul}            [Francci3_0708]{.ul}   [764]{.ul}    hypothetical protein              Francci3_3336            796
  [SecE subunit]{.ul}                         [Francci3_0567]{.ul}     [1339]{.ul}    [transcription factor WhiB]{.ul}     [Francci3_3759]{.ul}   [751]{.ul}    *hypothetical protein*            *Francci3_2440*          *781*
  Excisionase/Xis, DNA-binding                Francci3_0099            1327           **UspA**                             **Francci3_2760**      **747**       *hypothetical protein*            *Francci3_4509*          *778*
  [hypothetical protein]{.ul}                 [Francci3_3791]{.ul}     [1315]{.ul}    [exodeoxyribonuclease III]{.ul}      [Francci3_1180]{.ul}   [747]{.ul}    putative copper resistance        Francci3_2497            771
  [ATP synthase F0, A subunit]{.ul}           [Francci3_3713]{.ul}     [1263]{.ul}    hypothetical protein                 Francci3_1832          737           transcriptional regulator         Francci3_0210            765
  30S ribosomal proteinS1                     Francci3_1057            1256           [protein of unknown function]{.ul}   [Francci3_2628]{.ul}   [714]{.ul}    hypothetical protein              Francci3_1090            764
  heat shock protein Hsp20                    Francci3_2174            1241           hypothetical protein                 Francci3_4509          714           hypothetical protein              Francci3_4156            760
  NAD(P) transhydrogenase, beta               Francci3_2948            1231           hypothetical protein                 Francci3_1650          709           RNA-binding S4                    Francci3_3479            747
  [putative transcriptional regulator]{.ul}   [Francci3_1674]{.ul}     [1218]{.ul}    [STAS]{.ul}                          [Francci3_0441]{.ul}   [701]{.ul}    **hypothetical protein**          **Francci3_1545**        **746**
  protein of unknown function                 Francci3_0450            1215           [molecularchaperoneDnaK]{.ul}        [Francci3_4352]{.ul}   [694]{.ul}    hypothetical protein              Francci3_3238            746
  [Alcohol dehydrogenase]{.ul}                [Francci3_1544]{.ul}     [1206]{.ul}    hypothetical protein                 Francci3_0159          693           hypothetical protein              Francci3_3301            737
  [putative DNA-binding protein]{.ul}         [Francci3_1949]{.ul}     [1203]{.ul}    [acyl transferase region]{.ul}       [Francci3_0991]{.ul}   [691]{.ul}    hypothetical protein              Francci3_1985            724
  glutaredoxin 2                              Francci3_0483            1202           regulatory protein GntR              Francci3_3218          690           [*Rhodanese-like*]{.ul}           [*Francci3_2753*]{.ul}   [*721*]{.ul}
  translation elongation factor Tu            Francci3_0580            1179           CRISPR-associated protein            Francci3_3346          680           Thiolase                          Francci3_2502            718
  [thioredoxin]{.ul}                          [Francci3_4537]{.ul}     [1165]{.ul}    hypothetical protein                 Francci3_1874          678           response regulator receiver       Francci3_0120            715
  cytochrome P450                             Francci3_4464            1164           [hypothetical protein]{.ul}          [Francci3_1935]{.ul}   [672]{.ul}    hypothetical protein              Francci3_0498            705
  hypothetical protein                        Francci3_2582            1156           IS630 family transposase             Francci3_1872          670           DNApolymeraseIIIsubunitalpha      Francci3_4168            703
  [hypothetical protein]{.ul}                 [Francci3_1534]{.ul}     [1106]{.ul}    [globin]{.ul}                        [Francci3_2581]{.ul}   [663]{.ul}    *hypothetical protein*            *Francci3_0037*          *693*
  [protein of unknown function]{.ul}          [Francci3_1406]{.ul}     [1054]{.ul}    hypothetical protein                 Francci3_4127          657           hypothetical protein              Francci3_3241            684
  Vesicle-fusing ATPase                       Francci3_2630            1041           [thioredoxin]{.ul}                   [Francci3_4537]{.ul}   [653]{.ul}    30SribosomalproteinS6             Francci3_4522            683
  HesB/YadR/YfhF                              Francci3_3121            1032           hypothetical protein                 Francci3_0066          644           putative hydrolase                Francci3_2567            682
  hypothetical protein                        Francci3_0532            1022           [Alcohol dehydrogenase]{.ul}         [Francci3_1544]{.ul}   [644]{.ul}    *transposase IS116/IS110*         *Francci3_2124*          *681*
  [acyl transferase region]{.ul}              [Francci3_0991]{.ul}     [1015]{.ul}    *hypothetical protein*               *Francci3_2440*        *642*         hypothetical protein              Francci3_1807            675
  Superoxide dismutase                        Francci3_2817            1013           Tetratricopeptide TPR_4              Francci3_1951          639           hypothetical protein              Francci3_1805            675
  hypothetical protein                        Francci3_2185            1007           **hypothetical protein**             **Francci3_0227**      **635**       hypothetical protein              Francci3_2364            675
  hypothetical protein                        Francci3_4343            1006           hypothetical protein                 Francci3_2315          634           hypothetical protein              Francci3_2380            671
  [*serine/threonine kinase*]{.ul}            [*Francci3_4051*]{.ul}   [*989*]{.ul}   hypothetical protein                 Francci3_4019          633           response regulator receiver       Francci3_4048            670
  [acyl-CoA dehydrogenase]{.ul}               [Francci3_1000]{.ul}     [989]{.ul}     [hypothetical protein]{.ul}          [Francci3_0949]{.ul}   [633]{.ul}    putative O-methyltransferase      Francci3_0204            670
  conserved hypothetical protein              Francci3_0096            986            [serine phosphatase]{.ul}            [Francci3_3249]{.ul}   [632]{.ul}    channel protein                   Francci3_3898            669
  hypothetical protein                        Francci3_3886            983            Amino acid adenylation               Francci3_2459          632           hypothetical protein              Francci3_2032            667
  [*Rhodanese-like*]{.ul}                     [*Francci3_2753*]{.ul}   [*982*]{.ul}   *transposase IS116/IS110*            *Francci3_2124*        *630*         hypothetical protein              Francci3_1459            664
  hypothetical protein                        Francci3_4042            973            [hypothetical protein]{.ul}          [Francci3_3417]{.ul}   [628]{.ul}    flavoprotein                      Francci3_1816            662
  **hypothetical protein**                    **Francci3_3999**        **971**        **Antibiotic biosynthesis**          **Francci3_0875**      **626**       hypothetical protein              Francci3_0160            660
  [protein of unknown function]{.ul}          [Francci3_2628]{.ul}     [958]{.ul}     [protein of unknown function]{.ul}   [Francci3_1406]{.ul}   [621]{.ul}    AMP-dependent synthetase          Francci3_1806            659
  [LuxR family regulator]{.ul}                [Francci3_3253]{.ul}     [958]{.ul}     hypothetical protein                 Francci3_3247          621           serine/threonine protein kinase   Francci3_3395            659
  50SribosomalproteinL24                      Francci3_0593            944            [hypothetical protein]{.ul}          [Francci3_2943]{.ul}   [620]{.ul}    hypothetical protein              Francci3_4161            655
  ribosomal protein S2                        Francci3_3581            936            transcription factor WhiB            Francci3_3790          618           hypC/hupF                         Francci3_1946            655
  hypothetical protein                        Francci3_2736            934            hypothetical protein                 Francci3_3997          618           hypothetical protein              Francci3_0494            655
  [hypothetical protein]{.ul}                 [Francci3_2269]{.ul}     [932]{.ul}     transcriptional regulator            Francci3_4158          614           transcriptional regulator         Francci3_0985            654
  hypothetical protein                        Francci3_2809            929            hypothetical protein                 Francci3_2184          610           Excisionase/Xis, DNA-binding      Francci3_1856            653
  acyl-CoA dehydrogenase-like                 Francci3_0053            915            [hypothetical protein]{.ul}          [Francci3_0054]{.ul}   [608]{.ul}    phosphohydrolase                  Francci3_1134            648
  **Antibiotic biosynthesis**                 **Francci3_0875**        **911**        CRISPR-associated protein            Francci3_0023          608           **SsgA**                          **Francci3_3418**        **646**
  2-oxoacid oxidoreductase                    Francci3_3248            906            Recombinase                          Francci3_2373          607           **major facilitator MFS_1**       **Francci3_2752**        **643**
  translationinitiationfactorIF-1             Francci3_0605            904            *CRISPR-associated protein*          *Francci3_3345*        *606*         Inorganic diphosphatase           Francci3_4310            636
  electron transfer flavoprotein              Francci3_3659            889            hypothetical protein                 Francci3_2219          606           hypothetical protein              Francci3_1032            636
  hypothetical protein                        Francci3_4326            884            hypothetical protein                 Francci3_3299          605           DNA-directed RNA polymerase       Francci3_3194            635
  50SribosomalproteinL33                      Francci3_0563            880            [LuxR family regulator]{.ul}         [Francci3_3253]{.ul}   [604]{.ul}    **chaperoninGroEL**               **Francci3_4398**        **635**
  hypothetical protein                        Francci3_3625            856            *hypothetical protein*               *Francci3_2101*        *604*         **UspA**                          **Francci3_2760**        **633**
  Cytochrome-c oxidase                        Francci3_2009            855            [transcriptional regulator]{.ul}     [Francci3_1674]{.ul}   [600]{.ul}    **Aldehyde dehydrogenase**        **Francci3_2944**        **632**
  GrpE protein                                Francci3_4353            846            *transcriptional regulator*          *Francci3_0908*        *596*         hypothetical protein              Francci3_1014            631

^1^Gene annotations and locus tag numbers are colored based on their presence in all three samples (bold), in the 3dN2 and 5dNH4 samples (italic), in the 3dN2 and 3dNH4 samples (underscore), in the 3dNH4 and 5dNH4 samples (italic/underscore), and in one of the three samples (normal font).

^2^RPKM (Reads per Kilobase Million) = (\# reads per ORF)/(size of ORF in kilobases × millions of reads in the dataset).

Comparison of the top 100 gene lists with each other (color coded in Table [2](#T2){ref-type="table"}) and construction of heat maps of all genes revealed that overall gene expression varied more with culture age (three versus five days) than culture condition (+/- NH~4~^+^), with 3dNH4 and 3dN2 clustering before the 5dNH4 sample (Figure [1](#F1){ref-type="fig"}). Gene dendrograms (left side of the figure) gave five clusters of genes (Groups I through V) that had within-group expression profiles consistent among the three culture conditions tested. The genes in each cluster are listed in Additional File [1](#S1){ref-type="supplementary-material"}: Gene_list.xls.

![**Heat map representation of pair-wise gene expression in each sample**. The dendrogram at the top of the figure indicates relatedness of the three samples based on overall gene expression values. The dendrogram on the left side of the figure orders genes into groups based on the divergence of expression values among the three samples. The colors display gene expression variance: red indicates a higher gene expression, green indicates lower expression and black indicates the median value. This figure was generated using a log scale of RPKM values.](1471-2180-11-192-1){#F1}

Group I genes are clearly down-regulated in 3dNH4 cells; these include 30 transporter related genes, five diguanylate cyclases and an array of putative N-controlled proteins such as assimilatory nitrate reductase, adenosine deaminase, allantoinase and nitrogen fixation (*nif*) genes in addition to 252 hypothetical proteins. Group II genes are up regulated in 3dN2 cultures and include most of the *nif*genes, genes involved in sulfur metabolism and iron-sulfur protein synthesis, cell division proteins and hydrogenase synthesis. The 3dN2 culture was prepared with a modified iron stock containing a higher concentration of iron sulphate and sodium molybdate \[[@B24]\]. We cannot rule out that an increase in iron-sulfur protein synthesis may be related to the increase in iron sulphate to the medium although it is more likely to be related to an increased demand for iron and molybdenum. Eight phage integrases were also present in Group II, which was the highest number of integrases present in any of the five groups. Group III contains genes that have relatively more transcripts in 5dNH4 cells; these include a larger proportion of hypothetical protein ORFs (523 ORFs) than were present in the other four groups (average of \~200 ORFs per group). All of the annotated excisionase/Xis ORFs were present in the Group III list, suggesting that phage-related excisionases are being transcribed more in the 5dNH4 sample than in the other conditions. Group IV genes were more abundantly transcribed in the 3dNH~4~^+^sample including several sigma factors; this group also had the fewest transposase ORFS (2 ORFs). Group V contains ORFs more highly expressed in younger cultures. ORFs in this grouping include 17 ribosomal protein ORFs, and a majority of the glycolytic enzymes.

As expected, *nif*ORFs were more highly expressed in the 3dN2 sample, with numerous vesicles present, than in the 3dNH4 sample and were in Group II on the heat map. The 5dNH4 culture also had *nif*expression above that detected in the 3dNH4 culture. Three *nif*ORFs were not significantly expressed in the 5dNH4 sample over the 3dNH4 sample as predicted by a Kal\'s ztest p value \[[@B25]\] (Table [3](#T3){ref-type="table"}). On the other hand, the genes for the core nitrogenase components nitrogenase reductase (*nifH*), and nitrogenase alpha and beta chains (*nifKD*) were upregulated in the 3dN2 sample, and were cotranscribed to similar extents within individual cultures, suggesting that they exist in an operon independent from the rest of the *nif*cluster. An intergenic space consisting of 208 nucleotides between these three ORFs and the rest of the cluster supports this analysis. The presence of *nif*transcripts in all cell types, even where ammonia should still be in excess, is in concert with the heterogeneous nature of the frankial growth habit, where mycelia develop microsites that are potentially nutrient deficient or microaerobic due to adjoining cell populations. The 5dNH4 cells are most likely depleted for combined nitrogen and, indeed, a few vesicles can be observed in older cultures. This observation highlights a fundamental problem with the mRNA deep sequencing of a *Frankia*culture where different cell physiologies can skew average gene expression in a culture. Apart from isolated vesicles \[[@B26]\] that are unlikely to give a sufficient quantity of mRNA for second generation sequencing technologies, long-read, single molecule sequencing techniques run in parallel could specifically sequence the transcriptome of distinct cell morphologies in a pure culture as was recently done with *Vibrio cholerae*\[[@B27]\].

###### 

Fold changes of *nif*cluster ORF expression levels^1^

  Feature ID      Annotation                                                       5dNH4 vs 3dNH4   3dN2 vs 3dNH4   3dN2 vs 5dNH4
  --------------- ---------------------------------------------------------------- ---------------- --------------- ---------------
  Francci3_4473   thiamine pyrophosphate enzyme-like TPP-binding                   1.28             1.89            1.48
  Francci3_4474   pyruvate flavodoxin/ferredoxin oxidoreductase-like               1.60             1.93            1.20
  Francci3_4475   aminotransferase, class V                                        2.90             1.52            0.90
  Francci3_4476   UBA/THIF-type NAD/FAD binding fold                               1.20\*           2.08            1.73
  Francci3_4477   HesB/YadR/YfhF                                                   2.09             2.00            0.04
  Francci3_4478   nitrogenase cofactor biosynthesis protein NifB                   1.35             2.17            1.61
  Francci3_4479   NifZ                                                             0.54             1.45            2.23
  Francci3_4480   nitrogen fixation protein NifW                                   2.49             2.14            0.16\*
  Francci3_4481   protein of unknown function DUF683                               2.81             1.75            0.61
  Francci3_4482   protein of unknown function DUF269                               0.23\*           1.44            1.77
  Francci3_4483   Dinitrogenase iron-molybdenum cofactor biosynthesis              1.82             2.03            1.12\*
  Francci3_4484   nitrogenase molybdenum-iron cofactor biosynthesis protein NifN   2.55             1.78            0.43
  Francci3_4485   nitrogenase MoFe cofactor biosynthesis protein NifE              1.47             1.92            1.31
  Francci3_4486   nitrogenase molybdenum-iron protein beta chain                   1.16\*           2.40            2.08
  Francci3_4487   nitrogenase molybdenum-iron protein alpha chain                  1.62             2.94            1.82
  Francci3_4488   nitrogenase iron protein                                         1.34             3.71            2.77

^1^Fold changes calculated as quotients of RPKM values

\* Insignificant p value as determined by Kal\'s ztest.

Insertion Sequences
-------------------

Recent studies on *Frankia*proteomes have indicated the presence of several transposases in CcI3 grown in culture and in symbiosis \[[@B28]\], raising the question of how IS elements behave in cultured CcI3 cells. Given the number of transposase ORFs in the CcI3 genome (148 complete plus 53 fragments identified by PSI-BLAST analysis \[[@B2]\]), mRNA deep sequencing provides an efficient method of quantifying their behavior in cultures grown under different conditions.

RPKM values for the transposase ORFs were plotted against the locations of IS elements in strain CcI3 (Figure [2](#F2){ref-type="fig"}; \[[@B3]\]). Additional files [2](#S2){ref-type="supplementary-material"}, [3](#S3){ref-type="supplementary-material"}, [4](#S4){ref-type="supplementary-material"}, [5](#S5){ref-type="supplementary-material"}, [6](#S6){ref-type="supplementary-material"} and [7](#S7){ref-type="supplementary-material"} list the calculated expression data for the transposase ORFs. Transposase transcripts were generally more abundant than the transcriptome\'s median RPKM value (dashed line; values respective of sample) throughout the genome. The visual representation of transcript abundance in Figure [2](#F2){ref-type="fig"} indicates that transposase ORFs were overall more highly expressed in older cultures and, to a lesser extent, in N~2~fixing cells than in younger, nutrient sufficient cultures. Seventy-three transposase ORFs in the 5dNH4 sample were more highly expressed with respect to the 3dNH4 sample (Figure [2](#F2){ref-type="fig"}; Additional file [8](#S8){ref-type="supplementary-material"}: SNP_call_list.xls). Only 29 transposase ORFs were shown statistically to have higher expression in 3dNH4 than in 5dNH4. A similar trend was noticed in the 3dN2 vs 3dNH4 sample, with 91 transposase ORFs having statistically significant higher expression values in the 3dN2 sample. Many transposase ORFs had similar expression in the 3dN2 vs 3dNH4 and the 5dNH4 vs 3dNH4 comparisons. This is reflected in the ztest p values, as the 3dN2 vs 3dNH4 comparison had 50 changes with p values greater than 0.05 and the 5dNH4 versus 3dNH4 comparison had 48 changes with p values greater than 0.05. The majority of the insignificant p values in the comparisons are due to similarity of RPKM values.

![**Plot of transposase transcript RPKM values against previously determined transposase gene clusters**. Scale on the bottom represents the genome coordinates in Mb. The red line indicates the density of transposase ORFs in a 250 kb moving window in the CcI3 genome. Blue bars indicate RPKM values of each transposase ORF in the indicated growth conditions. The dotted line indicates the median RPKM value for all ORFs within the sample. Grey boxes indicate previously determined active deletion windows \[[@B3]\]. An IS66 transposase transcript having an RPKM value greater than 1600 in all three samples is indicated with a broken line.](1471-2180-11-192-2){#F2}

One IS66 transposase (Locus tag: Francci3_1864) near the 2 Mb region of the genome had an RPKM greater than 1600 in all samples. The majority of these reads were ambiguous. This transposase has five paralogs with greater than 99% nucleotide similarity, thereby accounting for ambiguous reads, so the elevated RPKM, while still high, is distributed among several paralogs. Other transposase ORFs with RPMK values higher than the median were more likely to be present in CcI3 deletion windows (gray boxes \[[@B3]\]) as determined by a Chi Square test against the likelihood that high RPKM transposase ORFs would exist in a similar sized region of the genome at random (p value = 1.32 × 10^-7^). This observation suggests that any transposase found in these windows is more likely to be transcribed at higher levels than transposases outside of these regions.

The largest change in expression was found in an IS3/IS911 ORF between the 5dNH4 and 3dNH4 samples. This ORF (locus tag: Francci3_1726, near 1.12 Mb) was expressed eleven fold higher in the 5dNH4 sample than in the 3dNH4 sample. Five other IS66 ORFs are also highly expressed in 5dNH4 ranging from 4 fold to 5 fold higher expression than in the 3dNH4 sample. Eight IS4 transposases had no detected reads under the alignment conditions in each growth condition. These eight IS4 transposases are members of a previously described group of 14 paralogs that have nearly 99% similarity in nucleic acid sequence \[[@B3]\]. Parameters of the sequence alignment used allowed for ten sites of ambiguity, therefore discarding reads from eight of these 14 duplicates as too ambiguous to map on the reference genome. Graphic depictions of assembled reads derived from raw CLC workbench files show that the majority of reads for the six detected IS4 transposases mapped around two regions. Both of these regions contained one nucleotide difference from the other eight identical transposases. *De novo*alignment of the unmapped reads from each sample resulted in a full map of the highly duplicated IS4 transposase ORFs (data not shown).

More globally, the 5dNH4 and 3dN2 samples had higher RPKM values per transposase ORF than in the 3dNH4 sample. The sum of the RPKM values among the transposase data set placed the 5dNH4 sample (34350 sum RPKM) and the 3dN2 (36150 sum RPKM) each nearly 30% higher than in 3dNH4 (26916 sum RPKM). The numbers of transposase genes classified as upregulated in the heat maps in Figure [1](#F1){ref-type="fig"} include 44 in 3dN2 cells, 40 in 5dNH4 cells and only two in 3dNH4 cells. Twenty-eight were down regulated in the 3dNH4 cells as shown by the heat map analysis (Additional File [8](#S8){ref-type="supplementary-material"}: SNP_call_list.xls). These results suggest a relative quiescence of transposase ORFs during healthy growth, and a burst of transcription when cells are stressed. Mutagenesis of genes involved in general metabolic pathways in *Escherichia coli*has been shown to promote earlier transposition of an IS5 family insertion sequence \[[@B29]\]. Media supplements to the mutated cells were shown to delay transposition events, thereby showing general starvation responses were likely involved in increased IS element activity \[[@B29]\].

The expression of *nif*cluster genes in the 5dNH4 sample suggests that the ammonium content of the medium was depleted, or nutrient deprived microsites had developed among the mycelia. One of the highly expressed non-ribosomal ORFs is the pyrophosphohydrolase gene *hisE*(Francci3_4317), suggesting that the amino acid histidine is in short supply. Additionally, a serine O-acetyltransferase was highly expressed in 5dNH4 cells, indicating activity in the cysteine synthesis pathway. Higher expression of both *ppx/gppA*ORFs (Locus tags: Francci3_0472 and Francci3_3920) in the 5dNH4 sample suggests that the stringent response \[[@B30]\] is active in response to amino acid deprivation. Two ORFs annotated as (p)ppGpp synthetases (Locus tags: Francci3_1376 and Francci3_1377) were actually more highly expressed in 3dN2 and 3dNH4 cells than in 5dNH4 cells.

Transcription of IS elements does not directly correlate to translation \[[@B31]\]. Many IS elements prevent their own transposition by requiring a -1 frame shift mutation in the transcript in order to express a functional transposase protein \[[@B32]\]. Since the specific methods of translational control used by *Frankia*IS elements are unknown, transcriptome data alone cannot be used as a proportional metric for transposition activity. On the other hand, recent proteomic studies on the CcI3 genome have confirmed that translation of many IS elements does occur *in vivo*and in symbiosis \[[@B16],[@B33]\].

RT-qPCR confirmation of transposase transcription
-------------------------------------------------

Duplicated copies of highly similar transposase ORFs presented a problem in the analysis of transcript sequence data. To compare transcription frequencies of duplicated ORFs in different culture conditions, we used RT-qPCR to amplify conserved regions of eight duplicated transposase ORF families using primers designed to amplify conserved regions in each group. The duplicates had greater than 98% nucleotide similarity with each other. The glutamine synthetase I (*glnA*) gene was used to normalize expression data as previously described \[[@B34]\]. We included a five-day old nitrogen fixing (5dN2) condition in our assay to better estimate transposase ORF expression in two older culture conditions (5dN2 and 5dNH4).

The results of the RT-qPCR assay confirmed the transcriptome sequence data (Figure [3](#F3){ref-type="fig"}). Comparing the five-day samples with three-day samples revealed an increase in transposase ORF transcription in older cultures in nearly all cases (Figure [3a](#F3){ref-type="fig"}). The only exception was in the case of the Tn3 family of transposases where transcription was predicted to be higher (fold change values less than one) at three days in both conditions. This may be due to transposition immunity described for other members of the Tn3 family \[[@B35]\]. Cross comparisons of NH4 and N2 samples revealed that nitrogen fixing cultures had more transposase transcripts from these duplicated families than from the ammonium cultures at both time points (Figures [3b](#F3){ref-type="fig"} and [3c](#F3){ref-type="fig"}). The most dramatic change in transcript quantity was found for the IS4 transposases\' transcripts in the 5dN2 sample that were 7.4 fold higher than levels in the 3dNH4 sample. As the representative transposase ORFs chosen for the RT-qPCR analysis were families of duplicates, a direct comparison of RT-qPCR fold change to transcriptome RPKM values was difficult to make. Still, the results of this experiment confirm the general trend of transposase ORF transcription in *Frankia*sp. CcI3: older and nitrogen-deprived cultures had higher transcription of transposase ORFs.

![**Results of the RT-qPCR assay of highly duplicated transposase ORFs**. All values indicate relative fold increase of transcription between samples standardized against *glnA*transcript levels. Panel A - fold changes of transcripts between five day and three day time points of cultures grown on N2 (black bars) or NH4 (gray bars). Panel B: fold changes of 5dN2 vs 3dNH4. Panel C: fold changes of 3dN2 vs 5dNH4 transposase ORFs respectively. The table (inset) indicates the copy number of duplicated transposase ORFs within each IS group as well as the locus tag of one of the representative members of that group. Error bars indicate standard error of triplicate reactions over each histogram.](1471-2180-11-192-3){#F3}

Prophage and CRISPRs
--------------------

ORFs with phage-related annotations were all more highly transcribed in the five-day sample with respect to both three-day samples (Table [4](#T4){ref-type="table"}). Several ORFs annotated as phage integrases were expressed more than two-fold in the 5dNH4 sample when compared to the 3dNH4 sample. Comparisons of fold change among all three samples yielded many statistically insignificant differences as determined by a Kal\'s z-test suggesting that these ORFs are likely transcribed at similar rates regardless of culture conditions. A phage SPO1 DNA polymerase-related protein (Francci3_0075) was constitutively expressed in all three samples, and four phage resistance ORFs were up-regulated in the 5dNH4 sample. The latter include members of the *pspA*and *pgl*(Phi C31) families of phage resistance genes. Similar RPKM values between the two *pgl*ORFs in all three samples suggest that these ORFs are transcribed as an operon in CcI3.

###### 

Fold changes of phage related ORFs^1^

  Feature ID      Annotation                                       5dNH4 vs 3dNH4   3dN2 vs 3dNH4   3dN2 vs 5dNH4
  --------------- ------------------------------------------------ ---------------- --------------- ---------------
  Francci3_0075   phage SPO1 DNA polymerase-related protein        -1.02\*          1.19\*          1.21\*
  Francci3_0114   phage integrase                                  -1.10\*          1.54            1.70
  Francci3_0407   phage integrase                                  1.48             1.23            -1.20
  Francci3_0878   phage integrase                                  1.05\*           1.55            1.48
  Francci3_1095   phage integrase                                  1.46             1.62            1.11
  Francci3_1144   phage integrase                                  2.72             1.63            -1.67
  Francci3_1203   phage integrase                                  1.39             1.66            1.20
  Francci3_1870   phage integrase-like SAM-like                    3.05             1.53            -2.00
  Francci3_2053   phage integrase-like SAM-like                    -1.32            1.83            2.43
  Francci3_2147   phage integrase                                  1.92             1.52            -1.26
  Francci3_2228   phage shock protein A, PspA                      2.47             1.43            -1.73
  Francci3_2304   phage integrase                                  1.60             -1.24\*         -1.99
  Francci3_2344   phage integrase                                  1.59             1.20\*          -1.32
  Francci3_2443   putative phage-related terminase large subunit   1.34             1.84            1.37
  Francci3_2954   bacteriophage (phiC31) resistance gene PglY      1.57             1.38            -1.14\*
  Francci3_2955   bacteriophage (phiC31) resistance gene PglZ      1.47             1.22\*          -1.21\*
  Francci3_3052   phage integrase                                  1.07\*           1.43            1.34
  Francci3_3350   phage integrase                                  1.42             1.74            1.22
  Francci3_3388   phage integrase                                  1.55             1.84            1.19
  Francci3_3390   phage integrase                                  1.89             -1.09\*         1.73
  Francci3_3532   phage integrase                                  2.02             1.48            -1.36
  Francci3_3535   phage shock protein A, PspA                      -1.98            -1.86           1.06\*
  Francci3_3583   phage integrase                                  -1.34            1.39            1.86
  Francci3_3734   phage integrase-like SAM-like                    1.34             1.62            1.21
  Francci3_4274   phage integrase                                  4.52             1.60            -2.83
  Francci3_4338   phage integrase                                  -1.36            1.69            2.30

^1^Fold changes calculated as quotients of RPKM values

\*Insignificant p value as determined by Kal\'s ztest.

Negative values indicate a fold reduction of expression in the reference (later) condition.

CcI3 has four putative CRISPR arrays, two of which are located near clusters of CAS ORFs (data obtained from CRISPRFinder \[[@B36]\]). Three of the CRISPR arrays had high numbers of repeat copies (38, 15 and 20 spacers per array ordered with respect to the OriC) making alignment of ambiguous sequence reads difficult. Even the shorter 36 bp read lengths of the 5dNH4 sample could not be reliably mapped across the arrays using the CLC Genome Workshop alignment programs. As a result, few reads mapped to the array region of the CRISPR islands and numerous deletions were predicted (Additional Files [2](#S2){ref-type="supplementary-material"} through [7](#S7){ref-type="supplementary-material"}). The CAS ORF transcripts, by contrast, were detected in all three samples. Again, transcription was modestly higher in the 5dNH4 sample than in the 3dNH4 sample (Table [5](#T5){ref-type="table"}). In this instance, the 3dN2 sample had nearly two fold higher expression of all CAS ORFs when compared with the 3dNH4 sample. Comparison of the 5dNH4 and 3dN2 samples revealed insignificant fold changes as determined by a Kal\'s ztest.

###### 

Fold changes of CRISPR associated ORFs^1^

  Feature ID      Annotation                              5dNH4 vs 3dNH4   3dN2 vs 3dNH4   3dN2 vs 5dNH4
  --------------- --------------------------------------- ---------------- --------------- ---------------
  Francci3_0017   CRISPR-associated helicase Cas3, core   1.31             1.39            1.06\*
  Francci3_0020   CRISPR-associated protein, CT1975       2.99             1.63            -1.84
  Francci3_0021   CRISPR-associated protein, CT1976       2.79             1.42            -1.96
  Francci3_0023   CRISPR-associated protein Cas1          1.31             1.57            1.20
  Francci3_0024   CRISPR-associated protein, Cas2         1.16             1.31            1.13\*
  Francci3_3341   CRISPR-associated helicase Cas3, core   1.29             1.35            1.05\*
  Francci3_3344   CRISPR-associated protein TM1801        1.04\*           1.45            1.39
  Francci3_3345   CRISPR-associated protein Cas4          1.97             1.36            -1.44
  Francci3_3346   CRISPR-associated protein Cas1          1.14             1.29            1.13

^1^Fold changes calculated as quotients of RPKM values

\*Insignificant p value as determined by Kal\'s ztest.

Negative values indicate a fold reduction of expression in the reference (later) condition.

SNP detection
-------------

Given the base pair resolution of RNA sequencing, it is possible to identify single nucleotide polymorphisms (SNPs). Recent analysis of the bovine milk transcriptome revealed high fidelity of SNP calls derived from an RNA-seq experiment, though the authors caution that stringent criteria are necessary to reduce false positive calls \[[@B37]\]. Using similar filtering criteria, we identified 215 SNPs in the 5dNH4 sample, 365 SNPs in the 3dN2 sample and 350 SNPs in the 3dNH4 sample. Comparison of the SNP populations revealed that the 5dNH4 sample had substantially different SNP calls than the 3dN2 and 3dNH4 samples. Only 21 of the putative SNPs were found in all three samples (Table [6](#T6){ref-type="table"}). Twelve of these common SNPs resulted in non-synonymous amino acid changes.

###### 

Detected SNPs present in all three samples

  Locus tag       Annotation                                      Position   **Reference**^**1**^   **Variants**^**2**^   Amino Acid Change
  --------------- ----------------------------------------------- ---------- ---------------------- --------------------- -------------------
  Francci3_0398   putative DNA-binding protein                    452        G                      G/A                   Arg -\> Gln
  Francci3_1612   NLP/P60                                         356        G                      G/A                   Arg -\> Gln
                                                                  375        A                      A/C                   Gln -\> His
  Francci3_1959   Transposase, IS110                              1109       G                      G/A                   Gly -\> Asp
  Francci3_2025   Transposase, IS4                                81         G                      A/G                   \-
                                                                  91         C                      C/T                   Arg -\> Cys
                                                                  119        T                      T/C                   Val -\> Ala
  Francci3_2063   hypothetical                                    310        A                      A/C                   Met -\> Leu
                                                                  313        C                      C/T                   Pro -\> Ser
                                                                  333        C                      C/T                   \-
                                                                  353        A                      A/G                   Glu -\> Gly
  Francci3_3047   Radical SAM                                     93         G                      G/C                   \-
  Francci3_3251   putative signal transduction histidine kinase   293        T                      C/T                   Val -\> Ala
  Francci3_3418   SsgA                                            165        C                      T/C                   \-
  Francci3_4082   dnaE                                            3579       T                      C/T                   \-
                                                                  3601       G                      G/A                   Glu -\> Lys
  Francci3_4107   Integrase                                       135        C                      C/T                   \-
  Francci3_4124   Recombinase                                     162        T                      T/A                   \-
                                                                  168        C                      T/C                   \-
  Francci3_4157   Hypothetical                                    36         C                      C/T                   \-
                                                                  49         A                      A/G                   Ser -\> Gly

^1^The nucleotide present in the reference genome sequence of *Frankia*sp. CcI3.

^2^The predicted allelic variants for the reference position nucleotide. The most common polymorphic nucleotide is listed first in the proportion.

There are several possibilities that may explain the variance of SNP content between the 5dNH4 sample and the two three day samples. The age of the culture is a possible, yet unlikely, contributor to a significantly different SNP pattern. *Frankia*strains are maintained by bulk transfer of cells since derivation from single colonies is problematical due to the hyphal habit of growth. Thus, over time, SNPs likely arise spontaneously. Another possibility is that errors are incorporated into the mRNA-seq libraries resulting in false positive SNPs. The Superscript III^©^reverse transcriptase used in the first strand cDNA synthesis was derived from a MML virus \[[@B38]\] and has an error rate of approximately 3.0 × 10^-5^errors per base \[[@B39]\]. Therefore, only SNPs detected in all three samples with high coverage and multiple variant copies were likely true positive SNPs.

Conclusions
===========

We deep-sequenced dscDNA libraries derived from three culture conditions of *Frankia*sp. CcI3. Overall gene expression varied more as a function of culture age than as a function of nitrogen deprivation, likely because the cell population has fewer actively growing cells at the fifth day of culture and those remaining are adapting to nutrient deprivation. In two limited nutrient environments, transposase ORFs were relatively more highly expressed than in younger ammonium grown cells. A RT-qPCR assay designed to quantify highly duplicated transposase ORFs supported the data from the mRNA-seq experiment. These results, in tandem with discovery of putative SNPs, suggests that the IS element laden CcI3 genome is in constant flux within the relatively mundane conditions of a culture flask.

Methods
=======

Culture media and conditions
----------------------------

Frozen stocks of *Frankia*sp. strain CcI3, were suspended in duplicate in 200 ml of *Frankia*Defined Minimal media (FDM) containing 45 mM sodium pyruvate and 9.3 mM ammonium chloride in 500 ml flasks \[[@B40]\]. Cells were grown at 30°C for three or five days on FDM with or without (N~2~fixing cells) ammonium. Nitrogen fixing cultures were prepared using a modified iron stock as previously described \[[@B24]\]. Given the difficulty in quantifying viable *Frankia*cells in culture, a total of three ml of gravity-settled cells were harvested per culture flask for RNA extraction.

RNA extraction
--------------

*Frankia*cells were processed using a ZR Fungal/Bacterial RNA MiniPrep™ kit from Zymo Research^©^(<http://www.zymoresearch.com>) using the manufacturer\'s recommendations. To completely remove genomic DNA (gDNA) contamination from the RNA extraction, we performed the in-column DNAse I optional step using Amplification grade DNAse I (Invitrogen™, <http://www.invitrogen.com>). DNAseI incubation times were extended to 30 minutes at 37°C in order to completely remove gDNA from the sample. A final elution volume of 15 μl of RNAse free water was used instead of the recommended 6 μl elution volume. Only RNA samples with a 260/280 nm wavelength ratio above 2.00 were used for library construction and RT-qPCR assays.

In order to enrich mRNA content for generating a cDNA library, we used the MICROBExpress™ Bacterial mRNA Enrichment Kit (Ambion Inc., <http://www.ambion.com>). The manufacturer\'s website specifies that the oligonucleotide sequence used by the kit should anneal to the 16S and 23S rRNA sequences of many eubacterial species including *Frankia*sp. Approximately 10 μg of *Frankia*total RNA in each condition was processed using the kit per the manufacturer\'s instructions. This procedure yielded 2 - 3.75 μg of RNA after depletion for each sample. Subsequent gel analysis and sequencing data revealed substantial 16S and 23S rRNA within the sample, suggesting only partial depletion of rRNA transcripts. Samples were nonetheless prepared using the depletion kit in order to minimize variability due to differential handling in the experiment.

Complementary DNA library generation
------------------------------------

One microgram of processed *Frankia*RNA was used in an Illumina mRNA-seq kit. The poly-dT pulldown of polyadenylated transcripts was omitted, and the protocol was followed beginning with the mRNA fragmentation step. A SuperscriptIII^©^reverse transcriptase was used instead of the recommended SuperscriptII^©^reverse transcriptase (Invitrogen™). This substitution was made in light of the higher G+C% of *Frankia*sp. transcripts (71% mol G+C) and the ability of the SuperscriptIII^©^transcriptase to function at temperatures greater than 45°C. Because of this substitution, the first strand cDNA synthesis stage of the protocol could be conducted at 50°C instead of 42°C. Since a second-strand cDNA synthesis was performed, the cDNA library was agnostic with respect to the strandedness of the initial mRNA. The final library volumes were 30 μl at concentrations of 40 - 80 ng/μl as determined by Nanodrop spectrophotometer.

Library clustering and Illumina platform sequencing
---------------------------------------------------

Prior to cluster generation, cDNA libraries were analyzed using an Agilent^©^2100 Bioanalyzer (<http://www.chem.agilent.com>) to determine final fragment size and sample concentration. The peak fragment size was determined to be approximately 200 +/- 25 bp in length for each sample. Twenty nmoles of each cDNA library were prepared using a cluster generation kit provided by Illumina Inc. The single-read cluster generation protocol was followed. Final cluster concentrations were estimated at 100,000 clusters per tile for the five day sample and 250,000 clusters per tile for the two three day samples on each respective lane of the sequencing flow-cell.

An Illumina^®^Genome Analyzer IIx™ was used in tandem with reagents from the SBS Sequencing kit v. 3 in order to sequence the cDNA clusters. A single end, 35 bp internal primer sequencing run was performed as per instructions provided by Illumina^®^. Raw sequence data was internally processed into FASTQ format files which were then assembled against the *Frankia*sp. CcI3 genome \[Genbank: [CP000249](CP000249)\] using the CLC Genomics Workbench™ software package distributed by CLC Bio^©^.

*Frankia*sp. CcI3 has a several gene duplicates. This made the alignment of the short reads corresponding to the gene duplicates difficult. Reads could only be mapped to highly duplicated ORFs by setting alignment conditions to allow for 10 ambiguous map sites for each read. In the case of a best hit \"tie,\" an ambiguous read was mapped to a duplicated location at random. Without this setting, more than 20 ORFs would not have been detected by the alignment program simply due to nucleotide sequence similarity.

To standardize gene expression calculations among different samples, the CLC Genomic Workbench software calculates an expression value termed \"reads per kilobase million\" (RPKM). This calculation incorporates variable gene length in the gene expression ratio, and the total number of reads obtained from a sequencing run \[[@B41]\]. The equation used to determine RPKM values is as follows:

$$\left. {RPKM} = {NumberofReads}\slash\left( {{Kilobaselengthofgene}*{Millionsofreadsindataset}} \right) \right.$$

The RPKM value allows comparisons between datasets containing variable numbers of reads as well as expression of genes with varying lengths. Because of the disparate quantities of rRNA reads among the three samples, we removed all non-coding RNA (ncRNA) reads from the data set before calculating RPKM values. This ensures that the reads from the 5dNH4 sample, which had the lowest number of ncRNA reads, were not overrepresented. Comparisons of gene expression were tested using Kal\'s Z-test \[[@B25]\]. Heat maps were generated using the Cluster 3.0 command line program (<http://bonsai.ims.u-tokyo.ac.jp/~mdehoon/software/cluster/software.htm>). Datasets were normalized and median subtracted prior to map generation. Maps were viewed using Java Treeview \[[@B42]\].

Potential SNPs were filtered using the following criteria: (1) reads containing putative SNPs were discarded if they had an average quality score of less than 15; (2) the polymorphic base within the read had to have a quality score above 20; (3) at least 10× coverage of the SNP position was required; (4) the SNP had to be present in 25% of the reads at that location. Raw sequence reads and calculated RPKM values for each CcI3 ORF were uploaded to the Gene Expression Omnibus database at NCBI (<http://www.ncbi.nlm.nih.gov/projects/geo>) with the accession number GSE30680.

RT-qPCR assays
--------------

The nucleotide sequences for the target transposase ORFs in *Frankia*strain CcI3 \[genbank: [CP000249](CP000249)\] were retrieved from Genbank. Primers were designed using the Primer3 webtool (<http://frodo.wi.mit.edu/primer3/>) with settings to generate primers with a melting temperature of \~60°C. Due to the limitations of extension time in quantitative polymerase chain reactions (qPCR), primers were designed to amplify less than 200 bp of sequence when possible.

Stocks of *Frankia*sp. CcI3 cells were grown in four culture conditions that included two time points and two medium types. Three of the conditions mirrored those used in the mRNA-seq experiment (3dN2, 3dNH4 and 5dNH4). A fourth condition, consisting of cells grown in nitrogen fixing medium for five days (5dN2), was also used. Cells were harvested and RNA was purified in the same manner as used in the mRNA-seq experiment. Approximately one micro-gram of RNA from each sample was used in subsequent reverse transcriptase reactions. Complementary DNA was synthesized using the SuperscriptIII^©^reverse transcriptase with gene specific primers (\~100 nM final concentrations per reaction mix). Synthesis of the first strand was carried out at 55°C for 50 minutes with a five minute denature step at 80°C. RT reactions were diluted ten-fold with sterile water after denaturation.

All qPCR experiments were performed using the Bio-Rad™ SsoFast^©^Evagreen qPCR 2X master mix. Reaction volumes were reduced to 12.5 μl. A Bio-Rad™ iQ5 real-time thermocycler was used to quantify reactions. Antibody denaturing of the SsoFast polymerase was performed at 95°C for 1.5 minutes immediately prior to any cycling step. This was followed by one 98°C denaturation for 2 minutes. Temperature cycling consisted of the following: 35 cycles of 98°C for 10 seconds then 55°C for 15 seconds and finally 65°C for 15 seconds. Melt curves (to determine if there were multiple PCR amplicons) were constructed by heating final amplified reactions from 65°C to 95°C for 10 seconds in single degree stepwise fashion. Primer efficiencies were calculated from readings derived from a standard curve of known DNA concentrations. Relative expression levels of target genes were calculated using the Pfaffl standardization as previously described \[[@B34]\]. The glutamine synthetase I gene (*glnA*) was used as a reference gene to standardize relative expression in the four samples.
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